KVUE Market Analysis
Wall Street coverage
third-party contextWall Street coverage
$19.50median target· current $19.27 (+1.2%)14 analysts
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
News & Sentiment
40 articles · sorted by datePage 1 of 2 · 40 total
Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.
Fundamentals
Updated daily after market closeP/E ratio21.94Forward 16.10
EPS (TTM)$0.886.0% YoY
Profit margin10.9%CONSUMER DEFENSIVE
Market cap$37.11BLarge cap
Valuation
- Forward P/E
- 16.10
- PEG ratio
- 1.53
- P/B
- 3.65
- P/S (TTM)
- 2.39
- EV/EBITDA
- 13.47
Profitability & growth
- ROE (TTM)
- 16.3%
- Operating margin
- 19.0%
- Revenue growth YoY
- 3.2%
- Dividend yield
- 4.2%
- Beta
- 0.45
Last earnings
Oct 30, 2026 · Estimate $0.28 · Reported $0.29
Analyst estimate. Actual results often differ.
Ratios are point-in-time. Historical metrics — no guarantees about what comes next.
About Kenvue Inc.
Company profileKenvue Inc. is a consumer health company globally.
Classification
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Exchange
- NYSE
- Country
- USA
- Currency
- USD
Company profile
- HQ
- 1 KENVUE WAY, SUMMIT, NJ
- Fiscal year end
- December
- Latest quarter
- Sep 30, 2026
Market cap$37.11B
Shares outstanding$1.92B
52W high$20.00
52W low$14.97
We're educators, not advisors. We don't make buy or sell recommendations under any circumstance. All content is for educational purposes. Past performance doesn't guarantee future results. Your decisions are your own. Disclaimer
Balanced Agent